CPHx: Peter Jabbour, Sponsored by BlueSEQ – An exchange for next-generation sequencing

An exchange for next-generation sequencing

Peter Jabbour, Sponsored by BlueSEQ

—–

A very new company, just went live last month.

What is an exchange?  A platform that brings together buyers and sellers within a market.  A web portal that helps place researchers, clinicians individuals, etc. with providers of next-gen sequencing services.

[web portals?  This seems very 1990s… time warp!]

Why do users need an exchange?  Users have limited access, need better access to technology, platvform, application, etc.

Why do providers need an exchange?  Providers may want to fill their queues.

[This is one stop shopping for next-gen sequencing providers?  How do you make money doing this?]

BlueSEQ platform: 3 parts.

  1. Knowledge Bank:  Comprehensive collection of continuously updated Next Generation Sequencing information, opinons, evaluations, tech bechmarks.
  2. Project Design: Standardized project parameters.  eg, de novo, etc. [How do you standardize the bioinformatics?  Seems… naive.]
  3. Sequencing exchange:  Providers get a list of projects that they can bid on.

[wow… not buying this. Keeps referring back to the model with airline tickets.]

Statistics will come out of the exchange – cost of sequencing, etc.

No cost to users.  Exchange fees for providers. [again, why would providers want to opt in to this?] 100 users have already signed up.

Future directions:  Specialized project desin tools, quoting tools, project management tools, comparison tools, customer reviews.

There are extensive tools for giving feedback, and rating other user’s feedback.

[Sorry for my snarky comments throughout.  This just really doesn’t seem like a well thought out business plan.  I see TONs of reasons why this shouldn’t work… and really not seeing any why it should.  Why would any provider want customer reviews of NGS data… the sample prep is a huge part of the quality, and if they don’t control it, it’s just going to be disaster.  I also don’t really see the value added component.  Good luck to the business, tho!]

 

6 thoughts on “CPHx: Peter Jabbour, Sponsored by BlueSEQ – An exchange for next-generation sequencing

  1. Pingback: Copenhagenomics » Recap of Day 1 at CPHx

    • Thanks for the reply! Actually, I wish those points had been made clearer during the presentation. They would have gone a long way towards answering the doubts I expressed. 9/10ths of the battle is going to be getting the sequencing groups to sign up – and if there are already 20 of them, that’s pretty significant. Did I miss that? I was listening pretty carefully for it.

      And, of course, I am still wondering what the presenter meant by standardizing bioinformatics. It was thrown in without a lot of context, so perhaps I misunderstood.

      I also have other questions about this business model – are you here at CPHx? and would have some time to answer a few other questions during a break? I’d be happy to write something up at the end, if you’d like.

      • Well, at the very least I think we’ve learned that the presentation needs some work to make things a little more clear. I’m here in Copenhagen as well as a couple of the “official” BlueSEQ folks. We’ll definitely try to find you today.

        • Hi Shawn,

          Thanks so much – I’ve had an opportunity to speak with Michael this morning, and he’s cleared up a lot of the misunderstandings. I’ll take the time to write a specific piece on BlueSEQ, although it may take a few days, as I will be without a computer once the conference ends this afternoon.

          After the conversation this morning, I have a much better appreciation of what BlueSEQ is trying to do and I’m a great supporter of the business model. I really wish the presentation had covered a few more of the salient points that I felt had been skipped.

  2. Pingback: BlueSEQ revisited | Fejes.ca

Leave a Reply

Your email address will not be published. Required fields are marked *